By Nigam Arora & Dr. Natasha Arora
MongoDB (MDB) is a database software stock. It is long from $24. It is trading at $450.00 up about $56 as of this writing in the aftermarket post-earnings. This represents a 1775% gain.
MDB earnings are better than the consensus.
MDB remains a buyout candidate. To date 167 of The Arora Report portfolio companies have been bought out producing a fortune for long-time subscribers.
At The Arora Report, we advocate diversifying by time frames ranging from very long term to very, very short term. Please see Trade Management Guidelines for six different time frames. MDB illustrates the power of long term investing.
Zones
This is a very long term position. The new target zone is $733 to $800.
For those following the Good Way, the Buy Now rating is ‘NO’.
For those following the Best Way, normally we give buy zones in advance but this stock is simply too volatile to give a buy zone for those who are not in MDB at this time.
What To Do Now
Those in the stock may consider continuing to hold.
Those not in the stock may wait for a signal on the Real Time Feed.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES,
TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
